Cardiopulmonary Exercise Testing and Metabolic Myopathies

Area of Science:

• Exercise Physiology
• Biochemistry
• Metabolic Myopathies

Background:

• Skeletal muscle ATP production increases significantly during exercise, primarily via oxidative phosphorylation.
• Metabolic defects affecting ATP production include disorders of glycogenolysis/glycolysis, mitochondrial myopathies, and lipid metabolism disorders.
• Cardiopulmonary exercise testing (CPET) analyzes exhaled gas to detect abnormalities in muscle metabolism.

Purpose of the Study:

• To evaluate the utility of CPET in identifying and differentiating defects in skeletal muscle ATP production.
• To correlate specific gas exchange patterns during CPET with distinct muscle metabolic disorders.
• To demonstrate how CPET can guide diagnosis and further investigation of exercise intolerance.

Main Methods:

• Gas exchange measurements (VO2, VCO2) during CPET.
• Analysis of exhaled gas to identify abnormal oxygen consumption and carbon dioxide production at the muscle level.
• Correlation of CPET findings with known muscle metabolic defects.

Main Results:

• Defects in glycogenolysis/glycolysis show low peak VO2 and absent excess VCO2 from lactic acid buffering.
• Mitochondrial myopathies present with low peak VO2, early lactic acid accumulation, and excess buffering-derived CO2.
• Lipid metabolism disorders cause only minor CPET abnormalities.
• Both glycogenolysis/glycolysis defects and mitochondrial myopathies can exhibit exaggerated cardiovascular response, low oxygen pulse, and increased ammonia release.

Conclusions:

• CPET is a valuable non-invasive tool for suggesting diagnoses of muscle metabolic disorders.
• Specific patterns of gas exchange abnormalities during CPET can differentiate between various types of metabolic defects.
• CPET findings can effectively guide clinicians in selecting appropriate follow-up investigations for exercise intolerance.